Device
STN DBS
STN DBS is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Cortical Network Modulation by Subthalamic Nucleus DBS
NCT04922411
completednot_applicable
Subthalamic Deep Brain Stimulation Effects on Decision-making Processing in Patients With Parkinson's Disease
NCT02231645
completedphase_2
Subthalamic Stimulation in Tourette's Syndrome
NCT02619084
Clinical Trials (3)
Showing 3 of 3 trials
NCT04922411Not Applicable
Cortical Network Modulation by Subthalamic Nucleus DBS
NCT02231645Not Applicable
Subthalamic Deep Brain Stimulation Effects on Decision-making Processing in Patients With Parkinson's Disease
NCT02619084Phase 2
Subthalamic Stimulation in Tourette's Syndrome
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3